Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Prolactin levels are higher in women with hirsutism but don't relate to its severity.

Hirsutism, often caused by PCOS, is treated with medication and weight loss is important for obese women with PCOS.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

MPA improved hormonal imbalances and acne in women with PCOS without affecting metabolism.

Spironolactone may help reduce hair growth and testosterone levels in some women with hirsutism.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Testosterone increases hair growth and acne in transgender men.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

The cream effectively reduces excessive hair growth and related skin issues without side effects.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.